IHH Annual Report 2024

233 Name of subsidiary Place of incorporation and business Principal activities Effective ownership interest and voting interest 2024 % 2023 % Indirect subsidiaries (continued) Held through Parkway Life Sante 8 SCI: Villers-Semeuse Invest ++ France Special purpose entity – Investment in real estate 32.95 – Held through Parkway Life Sante 9 SCI: SCI Turquoise ++ France Special purpose entity – Investment in real estate 32.95 – 1 PPL and PHL hold 99.99% and 0.01% shares in Parkway HK Holdings Limited respectively. 2 PPL and PHL hold 78.52% and 21.48% shares in Parkway Group Healthcare Pte. Ltd. (“PGH”) respectively. 3 PPL holds more than 99.99% shares in GDPL. The remaining shares are held by Gleneagles International Pte. Ltd. 4 GDPL and Parkway-Healthcare (Mauritius) Ltd. hold 97.86% (2023: 96.67%) and 1.29% (2023: 1.50%) shares in GHIPL respectively. 5 GDPL and PGH hold more than 99.99% and less than 0.01% in Parkway Healthcare India Private Limited respectively. 6 MRI and Shanghai Mai Kang Hospital Investment Management Co., Ltd. (“Shanghai Mai Kang”) hold 70% and 30% shares in Shanghai Rui Xin Healthcare Co., Ltd. respectively. 7 MRI and Shanghai Mai Kang hold 70% and 30% shares in Shanghai Rui Hong Clinic Co., Ltd. respectively. 8 MRI and Shanghai Mai Kang hold 70% and 30% shares in Shanghai Xin Rui Healthcare Co., Ltd. respectively. 9 Fortis and Fortis Health Management Limited (“FHML”) hold 74.35% and 25.65% shares in Fortis Hospotel Limited respectively. 10 Fortis and FHML hold 78.40% and 21.60% shares in International Hospital Limited (“IHL”) respectively. 11 Fortis and IHL hold 52% and 48% shares in FHML respectively. 12 Fortis, IHL and FHML hold 48.58%, 38.29% and 13.13% shares in Escorts Heart and Super Speciality Hospital Limited respectively. 13 Agilus Diagnostics Limited and Agilus Pathlabs Private Limited hold 50% shares each in DDRC Pathlabs Limited respectively. 14 Parkway Investments Pte. Ltd., PTM and Integrated Healthcare Holdings Limited hold 32.69% (2023: 35.25%), 0.23% (2023: 0.27%) and 0.03% (2023: 0.04%) of the units in PLife REIT respectively. 15 Parkway Life Nova Pte. Ltd. holds more than 99.99% shares in Parkway Life Sante SC. The remaining shares are held by Parkway Life Soleil SAS. 16 Parkway Life Sante SC holds more than 99.99% shares in the subsidiary. The remaining shares are held by Parkway Life Soleil SAS. # Audited by KPMG PLT. ## Audited by firms other than member firms of KPMG International. + Audit is not required. ++ Not required to be audited under the laws of country of incorporation. These special purpose entities have been consolidated in the financial statements in accordance with MFRS 10, as the Group primarily bears the risks and enjoys the benefits of the investments held by these special purpose entities. ^ The entity was granted approval by Companies Commission of Malaysia to have a financial year which does not coincide with the Company. 38. SUBSIDIARIES (continued)

RkJQdWJsaXNoZXIy NDgzMzc=